Delivery Order SPE2DB24D2101-SPE2DB25FKQCU
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Dupixent 300 mg/2 ml pen injections valued at $122,826.99. This firm fixed-price delivery order, with a completion date of September 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $391,967.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $13,735.17. This contract represents a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a $29,637.02 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $9,133.25 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, representing a short-duration pharmaceutical supply contract. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $27,045.49. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a ceiling value of $67,530.03. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026)....
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $59,030.74. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 10, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,964.65 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dupixent 300 mg/2 ml pen injections valued at $13,018.75 under a firm fixed-price contract. The delivery order, which concludes on September 11, 2025, represents a competitively awarded non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...